COVID19 Acute respiratory distress syndrome and extra-corporeal membrane oxygenation; A mere option or ultimate necessity

Extracorporeal membrane oxygenation (ECMO) is considered a salvage therapy in patients with acute respiratory distress syndrome (ARDS) and refractory hypoxemia (hypoxemia persisting despite lung-protective ventilation). One aspect of ECMO is whether there would be an application of the technology related to the Coronavirus pandemic. The number of people diagnosed with Coronavirus disease (COVID19) has crossed the five million mark on 9 August 2020, with a case fatality rate of 5.2%. Due to this exponential increase in the number of coronavirus disease (COVID19) cases particularly the ones associated with ARDS, experts are evaluating the need for ECMO in intensive care units. Herein, we chronicle a review encompassing the available evidence on ECMO and its potential role in COVID19 ARDS, as we aim for optimal patient care with appropriate resource utilization and conservation.

Download Full-text

The Decreasing Incidence of Late Posttraumatic Acute Respiratory Distress Syndrome: the Potential Role of Lung Protective Ventilation and Conservative Transfusion Practice

Yearbook of Critical Care Medicine ◽

10.1016/s0734-3299(08)70452-0 ◽

2008 ◽

Vol 2008 ◽

pp. 15-16

Author(s):

D.J. Dries

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Potential Role ◽

Distress Syndrome ◽

Transfusion Practice ◽

Protective Ventilation ◽

Lung Protective Ventilation

Download Full-text

The Role of Extracorporeal Membrane Oxygenation on Acute Respiratory Distress Syndrome

BioScientia Medicina ◽

10.32539/bsm.v5i10.362 ◽

2021 ◽

Vol 5 (10) ◽

pp. 953-960

Author(s):

Dini Ardiyani ◽

Zen Ahmad

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Lung Injury ◽

Extracorporeal Membrane Oxygenation ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Distress Syndrome ◽

Life Support ◽

Extracorporeal Life Support ◽

Lung Protective Ventilation ◽

Membrane Oxygenation

Acute lung injury and acute respiratory distress syndrome are characterized by rapid-onset respiratory failure following a variety of direct and indirect insults to the parenchyma or vasculature of the lungs. Extracorporeal membrane oxygenation is a form of extracorporeal life support where an external artificial circulator carries venous blood from the patient to a gas exchange device (oxygenator) where blood becomes enriched with oxygen and has carbon dioxide removed. This blood then re-enters the patients circulation. The potential advantages of ECMO over conventional manajement may extend beyond its role in supporting patients with ARDS. ECMO may facilitate and enhance the application of lung-protective ventilation by minimizing ventilator-induced lung injury.

Download Full-text

Therapeutic hypothermia as an adjunct to extracorporeal membrane oxygenation for acute respiratory distress and refractory hypoxemia

Perfusion ◽

10.1177/0267659118822941 ◽

2019 ◽

Vol 34 (5) ◽

pp. 422-424 ◽

Cited By ~ 1

Author(s):

Jessica G Y Luc ◽

Steven R Meyer ◽

William J Murtha ◽

Gurmeet Singh

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Extracorporeal Membrane Oxygenation ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

Therapeutic Hypothermia ◽

Distress Syndrome ◽

Community Acquired Pneumonia ◽

Successful Management ◽

Membrane Oxygenation ◽

Refractory Hypoxemia

Legionella community–acquired pneumonia necessitating veno-venous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome has been reported in adults. However, few options remain in cases of refractory hypoxemia on veno-venous extracorporeal membrane oxygenation. Herein, we describe adjunctive extended therapeutic hypothermia for refractory hypoxemia despite veno-venous extracorporeal membrane oxygenation for successful management of severe acute respiratory distress syndrome secondary to Legionella.

Download Full-text